Sluiter, R. L., van Marrewijk, C., de Jong, D., Scheffer, H., Guchelaar, H., Derijks, L., . . . Coenen, M. J. H. (2019). Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease. J Crohns Colitis.
Chicago-tyylinen lähdeviittausSluiter, Reinier L., et al. "Genotype-Guided Thiopurine Dosing Does Not Lead to Additional Costs in Patients With Inflammatory Bowel Disease." J Crohns Colitis 2019.
MLA-viiteSluiter, Reinier L., et al. "Genotype-Guided Thiopurine Dosing Does Not Lead to Additional Costs in Patients With Inflammatory Bowel Disease." J Crohns Colitis 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.